At present, the upstream raw materials of biochemical reagents mainly rely on imports. For the long-term development of the industry, the preparation technology of raw materials must be mastered.

C-luminary Biotech was founded in 2018 and is headquartered in Chengdu, China, with a research and development center in Suzhou and industrial platforms in Sichuan and Hunan, is a professional enterprise engaged in the research, development, production, and sale of in vitro diagnostic products.

To enhance the overall experience for both our exhibitors and visitors, the China IVD Supply Chain Expo in March 2024 will be divided into five specialized zones for Supply Chain, Consumables, General Lab Equipments, Components, and Raw Materials in addition to the CACLP show, which shall mainly present the Instruments and Reagents as well as International Pavilion.

The 4th China Key Raw Material & Parts Forum (CKRMPF) is scheduled to be held at Chongqing Yuelai International Conventional Center on 15 March in 2024.

The 3rd China Key Raw Material & Parts Forum (CKRMPF) was successfully wrapped up at Primus Hotel Nanchang International Expo City in May 2023.

The 3rd China Key Raw Material & Parts Forum (CKRMPF) is scheduled to be held at Primus Hotel Nanchang International Expo City on 28 May in 2023.

The data shows that the current average daily sales volume of self-test boxes has increased by more than 400 times compared with November.

The 2nd China Key Raw Material & Parts Forum was held on October 26, 2022 at the Conference Center of Nanchang Greenland Primus Hotel. More than 318,000 people watched the forum online through the People's Daily Health Client and CAIVD cloud platform!

On 29 September, Suzhou Novoprotein Scientific Co., Ltd. was listed on the STAR Market. The stock name is Novoprotein, the stock code is 688137. SH, with the issue price is 106.19 CNY / share, which broke after the opening, with a market capitalization of over CNY 5.6 billion.

Medix Biochemica, a Finnish producer of raw materials for in vitro diagnostics, said on Monday that it has acquired Bioresource Technology, a US-based provider of base matrices and other raw materials for IVD manufacturing.